Article

Comparison of infected and vaccinated transplant recipients highlights the role of Tfh and neutralizing IgG in COVID-19 protection

2021-07-24

Abstract excerpt

Transplant recipients, which receive therapeutic immunosuppression to prevent graft rejection, are characterized by high COVID-19-related mortality and defective response to vaccines. Having observed that previous infection by SARS-CoV-2 but not the standard “2 doses” scheme of vaccination, provided complete protection against COVID-19 to transplant recipients, we undertook this translational study to compare the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 172c1464-ae8a-5ed3-bd44-6e585656c46b
DOI: 10.1101/2021.07.22.21260852

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of infected and vaccinated transplant recipients highlights the role of Tfh and neutralizing IgG in COVID-19 protectionDOI 10.1101/2021.07.22.21260852Read

Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cellsSemantic proximity Read

B and T cell responses after a third dose of SARS-CoV-2 vaccine in Kidney Transplant RecipientsSemantic proximity Read

Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsSemantic proximity Read

Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccineSemantic proximity Read

High-affinity, neutralizing antibodies to SARS-CoV-2 can be made in the absence of T follicular helper cellsSemantic proximity Read

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsSemantic proximity Read

Impaired antigen-specific memory B cell and plasma cell responses including lack of specific IgG upon SARS-CoV-2 BNT162b2 vaccination among Kidney Transplant and Dialysis patientsSemantic proximity Read

A Third COVID-19 Vaccine Dose in Kidney Transplant Recipients Induces Antibody Response to Vaccine and Omicron Variants but Shows Limited Ig Subclass SwitchingSemantic proximity Read

Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell TherapySemantic proximity Read

HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTSSemantic proximity Read

Impact of Maintenance Immunosuppression Regimen on Anti-SARS-CoV-2 Antibody Kinetics In Kidney Transplant Recipients Receiving ChAdOx1 as Primary VaccinationSemantic proximity Read

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipientsSemantic proximity Read